There areresults for 'Overall ranking'
Pharma companies discuss 2014 Index performances
The Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor
Jayasree K. Iyer comments on GSK’s approach to IP and Patents on Access to Medicine
2018 Access to Medicine Index finds clear signs that pharmaceutical companies are deepening their strategic focus on Africa
Jayasree K. Iyer becomes Executive Director of the Access to Medicine Foundation
Meer beleggers willen goedkope medicijnen voor de armen
Governance & financials
Goldman Sachs & UBS to co-host investor launches of 2018 Access to Medicine Index
View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.